Trademark Overview
On Thursday, January 29, 2026, a trademark application was filed for FEVGRESLI with the United States Patent and Trademark Office. The USPTO has given the FEVGRESLI trademark a serial number of 99623446. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, March 24, 2026. This trademark is owned by Pfizer Inc.. The FEVGRESLI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use
